foto1 foto2 foto3 foto4 foto5


Our news

  • 18/07/2019: Pharegis implemented optimized procedures for state registration of pharmaceuticals in Eurasian Economic Union.
  • 20/06/2019: Pharegis updated timelines and practical approaches for Russian and EEU GMP inspection applications and procedures.
  • 03/04/2019:  Renewed general monographs of Russian state pharmacopeia XIV ed. have been analyzed.

Contact us

enarzh-CNfrdeiwitjakoptruessv

Regulatory Events Russia

November 2019
S M T W T F S
27 28 29 30 31 1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
December 2019
S M T W T F S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Russian Regulatory News

Pharegis LLC / ООО "Фареджис"
Address:
Business address:
3-1 Begovaya str. ("NordStar Tower", 31st flr), Moscow, Russia 125284

Legal & postal address:
11A-11 Cherkizovskaya B. str., Moscow, Russia 107392

PSRN: 1157746918933
TAX ID (TIN): 7718278100
D-U-N-S: 362071645

Phone:
+7 495 442 37 85 9am-6pm GMT+3
Fax:
+ 7 495 442 37 85
Mobile:
+ 7 985 908 58 18
Send an Email
(optional)
SHARE THIS BY:

News and press releases

  • Dutch authorities hand over final building to EMA in Amsterdam, , 15/11/2019
  • Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 November 2019 (updated), CHMP, 15/11/2019
  • EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots, CHMP, 15/11/2019
  • Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada, CHMP, 15/11/2019